Cuba develops medicine to combat Alzheimers
Cuban health officials have announced that the medication will undergo human clinical trials for the first time
In its efforts to halt the advance of Alzheimers and improve the quality of life of people suffering from the disease, Cuba announced the launch of human clinical trials on the medication NeuroEpo.




